{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-092780","form_type":"8-K","ticker":"OM","cik":"0001484612","company_name":"Outset Medical, Inc.","filed_at":"2024-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.210804+00:00","generated_at":"2026-05-31T11:42:21.010805+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Outset Medical Q2 revenue $27.4M (-24% YoY); FY2024 guidance cut to ~$110M from $145-153M","bullets":["Product revenue fell to $19.2M; service revenue rose 21.5% to $8.2M.","GAAP net loss $(0.66)/share; non-GAAP net loss $(0.47)/share.","Total gross margin improved to 35.7% from 21.4% YoY; non-GAAP gross margin 37.3%.","FY2024 revenue guidance revised to ~$110M (prior $145-153M); non-GAAP gross margin now low-to-mid 30%.","New console placements below expectations; company taking steps to improve execution."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-092780","json":"https://secwatch.observer/filing/0000950170-24-092780.json","markdown":"https://secwatch.observer/filing/0000950170-24-092780.md","text":"https://secwatch.observer/filing/0000950170-24-092780.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1484612/000095017024092780/0000950170-24-092780-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1484612/000095017024092780/om-20240807.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T11:42:21.010805+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}